Cargando…
Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria
By sequencing autozygous human populations, we identified a healthy adult woman with lifelong complete knockout of HAO1 (expected ~1 in 30 million outbred people). HAO1 (glycolate oxidase) silencing is the mechanism of lumasiran, an investigational RNA interference therapeutic for primary hyperoxalu...
Autores principales: | McGregor, Tracy L, Hunt, Karen A, Yee, Elaine, Mason, Dan, Nioi, Paul, Ticau, Simina, Pelosi, Marissa, Loken, Perry R, Finer, Sarah, Lawlor, Deborah A, Fauman, Eric B, Huang, Qin Qin, Griffiths, Christopher J, MacArthur, Daniel G, Trembath, Richard C, Oglesbee, Devin, Lieske, John C, Erbe, David V, Wright, John, van Heel, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108859/ https://www.ncbi.nlm.nih.gov/pubmed/32207686 http://dx.doi.org/10.7554/eLife.54363 |
Ejemplares similares
-
New Insights Regarding Organ Transplantation in Primary Hyperoxaluria Type 1
por: Sas, David J., et al.
Publicado: (2021) -
Primary hyperoxaluria type 1: novel therapies at a glance
por: Bacchetta, Justine, et al.
Publicado: (2022) -
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
por: Ticau, Simina, et al.
Publicado: (2021) -
Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant
por: Genena, Kareem M., et al.
Publicado: (2023) -
Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria
por: Tang, Xiaojing, et al.
Publicado: (2014)